Weiling Pu

658 total citations
22 papers, 493 citations indexed

About

Weiling Pu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Weiling Pu has authored 22 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Weiling Pu's work include Pancreatitis Pathology and Treatment (4 papers), Phytochemistry and biological activity of medicinal plants (3 papers) and Phagocytosis and Immune Regulation (3 papers). Weiling Pu is often cited by papers focused on Pancreatitis Pathology and Treatment (4 papers), Phytochemistry and biological activity of medicinal plants (3 papers) and Phagocytosis and Immune Regulation (3 papers). Weiling Pu collaborates with scholars based in China, Switzerland and Kazakhstan. Weiling Pu's co-authors include Li Sun, Kun Zhou, Ruyu Bai, Wenhua Li, Mengying Zhang, Yanfei Peng, Yingli Yu, Shiyue Zhou, Lei Song and Curzio Rüegg and has published in prestigious journals such as Molecules, Journal of Ethnopharmacology and Journal of Cellular Physiology.

In The Last Decade

Weiling Pu

21 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiling Pu China 11 286 97 76 62 61 22 493
Mohamed Katary Egypt 15 204 0.7× 89 0.9× 63 0.8× 53 0.9× 63 1.0× 47 590
Yanting You China 13 234 0.8× 86 0.9× 57 0.8× 27 0.4× 49 0.8× 36 517
Run-Yue Huang China 11 209 0.7× 139 1.4× 83 1.1× 83 1.3× 92 1.5× 15 480
Dake Cai China 14 274 1.0× 123 1.3× 61 0.8× 47 0.8× 44 0.7× 35 573
Yongqing Cai China 15 291 1.0× 80 0.8× 49 0.6× 88 1.4× 48 0.8× 29 612
Ji‐Yao Chou Hong Kong 13 213 0.7× 68 0.7× 68 0.9× 55 0.9× 62 1.0× 19 416
Nai-Dan Zhang China 10 349 1.2× 103 1.1× 73 1.0× 81 1.3× 37 0.6× 13 557
Zhang‐Bin Tan China 18 295 1.0× 108 1.1× 59 0.8× 38 0.6× 68 1.1× 30 584
Soha Osama Hassanin Egypt 16 214 0.7× 68 0.7× 63 0.8× 61 1.0× 31 0.5× 25 622

Countries citing papers authored by Weiling Pu

Since Specialization
Citations

This map shows the geographic impact of Weiling Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiling Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiling Pu more than expected).

Fields of papers citing papers by Weiling Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiling Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiling Pu. The network helps show where Weiling Pu may publish in the future.

Co-authorship network of co-authors of Weiling Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Weiling Pu. A scholar is included among the top collaborators of Weiling Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiling Pu. Weiling Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Hao, et al.. (2025). Rhein alleviates pancreatitis but induces hepatotoxicity via macrophage activation. Journal of Ethnopharmacology. 350. 120069–120069. 1 indexed citations
2.
Liu, Hao, et al.. (2024). Natural products with anti-tumorigenesis potential targeting macrophage. Phytomedicine. 131. 155794–155794. 6 indexed citations
3.
Qiu, Qi, Fei Fu, Chenxia Han, et al.. (2024). Rhei Radix et Rhizoma and its anthraquinone derivatives: Potential candidates for pancreatitis treatment. Phytomedicine. 129. 155708–155708. 3 indexed citations
4.
Han, Xiao, Siqi Zhang, Shenshen Yang, et al.. (2024). The role of NCAPH in cancer treatment. Cellular Signalling. 121. 111262–111262. 4 indexed citations
5.
Shao, Yingying, Weiling Pu, Yu Wang, et al.. (2024). Autocrine and paracrine LIF signals to collaborate sorafenib-resistance in hepatocellular carcinoma and effects of Kanglaite Injection. Phytomedicine. 136. 156262–156262. 2 indexed citations
6.
Lin, Xiaowei, Siqi Zhang, ZhiCheng Lai, et al.. (2024). Babaodan inhibits cell proliferation and metastasis and enhances anti-tumor effects of camrelizumab by inhibiting M2 phenotype macrophages in hepatocellular carcinoma. Journal of Ethnopharmacology. 334. 118540–118540. 1 indexed citations
7.
Han, Xiao, Feng He, Fang Wang, et al.. (2023). Active compounds and potential targets of Shuganning injection in the treatment of hepatocellular carcinoma by network pharmacology and in vitro validation. Naunyn-Schmiedeberg s Archives of Pharmacology. 396(9). 1943–1955.
8.
Wang, Yu, Weiling Pu, Sibao Chen, et al.. (2023). Dual identity of tumor-associated macrophage in regulated cell death and oncotherapy. Heliyon. 9(7). e17582–e17582. 4 indexed citations
9.
Wang, Lei, et al.. (2023). Metal ions as effectual tools for cancer with traditional Chinese medicine. 3(4). 296–308. 7 indexed citations
10.
Shao, Yingying, et al.. (2022). Anti-tumor pharmacology of natural products targeting mitosis. Cancer Biology and Medicine. 19(6). 1–28. 24 indexed citations
11.
Li, Huhu, et al.. (2022). Effects of Anthraquinones on Immune Responses and Inflammatory Diseases. Molecules. 27(12). 3831–3831. 25 indexed citations
12.
Li, Shuangfeng, Shuangshuang Yin, Shiyue Zhou, et al.. (2022). Polyphenols as potential metabolism mechanisms regulators in liver protection and liver cancer prevention. Cell Proliferation. 56(1). e13346–e13346. 39 indexed citations
13.
Zhang, Yunsha, Weiling Pu, Mélanie Bousquenaud, et al.. (2021). Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis. Frontiers in Oncology. 10. 564674–564674. 61 indexed citations
14.
Pu, Weiling, Mengying Zhang, Ruyu Bai, et al.. (2019). Anti-inflammatory effects of Rhodiola rosea L.: A review. Biomedicine & Pharmacotherapy. 121. 109552–109552. 149 indexed citations
15.
Zhang, Yue, Xiaomei Yuan, Yuefei Wang, et al.. (2019). Isopsoralen induces different subchronic toxicities and metabolomic outcomes between male and female Wistar rats. Regulatory Toxicology and Pharmacology. 103. 1–9. 12 indexed citations
16.
Pu, Weiling, Ruyu Bai, Kun Zhou, et al.. (2019). Baicalein attenuates pancreatic inflammatory injury through regulating MAPK, STAT 3 and NF-κB activation. International Immunopharmacology. 72. 204–210. 43 indexed citations
17.
Pu, Weiling, Li Sun, Xiumei Gao, et al.. (2017). Targeting tumor-associated macrophages by anti-tumor Chinese materia medica. Chinese Journal of Integrative Medicine. 23(10). 723–732. 3 indexed citations
18.
Pu, Weiling, Yingying Luo, Ruyu Bai, et al.. (2017). Baicalein inhibits acinar‐to‐ductal metaplasia of pancreatic acinal cell AR42J via improving the inflammatory microenvironment. Journal of Cellular Physiology. 233(8). 5747–5755. 25 indexed citations
19.
Pu, Weiling, Huijie Zhang, Meng Wang, et al.. (2017). Superior Stability of Hydroxysafflor Yellow A in Xuebijing Injection and the Associated Mechanism. Molecules. 22(12). 2129–2129. 5 indexed citations
20.
Yuan, Xiaomei, et al.. (2016). Psoralen and Isopsoralen Ameliorate Sex Hormone Deficiency-Induced Osteoporosis in Female and Male Mice. BioMed Research International. 2016. 1–8. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026